Drugs · acquisition-cost intelligence
ADVAIR HFA
fluticasone propionate and salmeterol xinafoate· ingredient salmeterolAdrenergics in combination with corticosteroids or other drugs, excl. anticholinergics· FLUTICASONE PROPIONATE 115 ug/1; SALMETEROL XINAFOATE 21 ug/1; FLUTICASONE PROPIONATE 230 ug/1; SALMETEROL XINAFOATE 21 ug/1; FLUTICASONE PROPIONATE 45 ug/1; SALMETEROL XINAFOATE 21 ug/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$22.72
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 7 weeks.
2025-11-192026-05-20
Same-ingredient options by acquisition cost
Other salmeterol products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| ADVAIR DISKUS | $1.33 | −$21.39 |
| ADVAIR DISKUS | $3.12 | −$19.60 |
| SEREVENT DISKUS | $6.74 | −$15.98 |
| Fluticasone Propionate and Salmeterol HFA | $20.32 | −$2.40 |
| AirDuo RespiClick | $110.30 | +$87.58 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.